Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome

Dan Li(Wuhan University), Zhi Zeng(Sun Yat-sen University)
Oxidative Medicine and Cellular Longevity
January 1, 2021
Cited by 19


Related Papers